Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice.
1994 · The Journal of Immunology · 379 citations
https://doi.org/10.4049/jimmunol.153.10.4349
D
David Baker
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
410
Papers
21.0K
Citations
76
h-index
247
i10-index
David Baker is an academic researcher from Quadram Institute. The author has contributed to research in topics: Multiple Sclerosis Research Studies & Immunotherapy and Immune Responses & Cannabis and Cannabinoid Research. The author has an h-index of 76, co-authored 349 publications.
ORCID: 0000-0002-8872-8711Papers by this author
worksChanges in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study
2021 · The Lancet Public Health · 339 citations
https://doi.org/10.1016/s2468-2667(21)00055-4
Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis
2017 · EBioMedicine · 282 citations
https://doi.org/10.1016/j.ebiom.2017.01.042
Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases
2023 · Nature Communications · 158 citations
https://doi.org/10.1038/s41467-023-40937-z
Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells
2018 · Journal of Neurology · 144 citations
https://doi.org/10.1007/s00415-018-8830-y
The role of adipokines in skeletal muscle inflammation and insulin sensitivity
2018 · Journal of Inflammation · 122 citations
https://doi.org/10.1186/s12950-018-0185-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat